Preview

User

Not a user? Register with this site Forgot your password?

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Fortelyzin in the treatment of acute ischemic stroke due to basilar-artery occlusion: data from the observational study FORPI registry

https://doi.org/10.14412/2074-2711-2026-2-36-44

Abstract

   The approach to reperfusion therapy for acute ischemic stroke (AIS) in cases of basilar artery occlusion (BAO) remains a matter of debate.

   Objective: to assess the safety and efficacy of Fortelyzin in patients with BAO in real-world clinical practice, based on data from the FORPI registry.

   Material and methods. The FORPI registry is an open-label, prospective, non-interventional observational study of Fortelyzin in patients with ischaemic stroke. An analysis was conducted of the safety and efficacy of Fortelyzin in a group of patients with basilar artery occlusion who underwent intravenous thrombolytic therapy (IVT) and bridging therapy. The safety endpoint was the incidence of symptomatic intracranial haemorrhage (SICH) as defined by ECASS III and SITS-MOST, as well as all-cause mortality at 90 days. The efficacy endpoint was defined as good functional recovery, defined as a score of 0–2 on the modified Rankin Scale (MRS) at 90 days.

   Results. This analysis included 1910 patients who underwent IVT and 53 patients who underwent bridging therapy. The median National Institutes of Health Stroke Scale (NIHSS) scores at admission were 9 and 12 points, respectively (p = 0.01). SICH incidence (ECASS III criteria) was significantly higher in the bridging therapy group compared to IVT group (6 % vs 1 %, p = 0.01). All-cause mortality at day 90 did not differ significantly between the groups (9 % and 7 %, respectively, p = 0.52). Good functional recovery at day 90 was achieved by 69 % of patients in the IVT group and 60 % of patients in the bridging therapy group (p = 0.31).

   Conclusion. The use of Fortelyzin in AIS patients with BAO may be considered an effective and safe form of reperfusion therapy, as well as a component of bridging therapy aimed at increasing the number of favorable functional outcomes.

About the Authors

N. A. Shamalov
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; Federal Center of Brain and Neurotechnologies, FMBA of Russia
Russian Federation

Nikolay Anatolyevich Shamalov

117997; 1, Ostrovityanova St.; 1, Ostrovityanova St., Build. 10; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



M. Yu. Martynov
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; Federal Center of Brain and Neurotechnologies, FMBA of Russia
Russian Federation

117997; 1, Ostrovityanova St.; 1, Ostrovityanova St., Build. 10; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



N. A. Marskaya
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Russian Federation

117997; 1, Ostrovityanova St.; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



D. R. Khasanova
Kazan State Medical University, Ministry of Health of Russia
Russian Federation

420012; 49, Butlerova St.; Kazan
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



E. B. Yarovaya
M.V. Lomonosov Moscow State University
Russian Federation

119991; 1, Leninskie Gory; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



I. A. Voznuk
Acad. I.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of Russia
Russian Federation

197022; 6-8, L'va Tolstogo St.; St. Petersburg
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



L. V. Timchenko
Research Institute – S.V. Ochapovsky Regional Clinical Hospital No. 1
Russian Federation

350086; 167, 1 Maya St.; Krasnodar
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



A. M. Alasheev
Sverdlovsk State Regional Clinical Hospital No 1
Russian Federation

620102; 185, Volgogradskaya St.; Yekaterinburg 
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



N. V. Khalo
I.S. Berzon Krasnoyarsk Interdistrict Clinical Hospital No. 20
Russian Federation

660123; 12, Instrumentalnaya St.; Krasnoyarsk
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



M. D. Bogatyreva
Stavropol Regional Clinical Hospital
Russian Federation

355029; 1, Semashko St.; Stavropol
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



D. S. Khan
Primorsky Regional Clinical Hospital No. 1
Russian Federation

690091; 57, Aleutskaya St.; Vladivostok
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



L. L. Korsunskaya
V.I. Vernadsky Crimean Federal University
Russian Federation

295007; 4, Akademika Vernadskogo Prosp.; Simferopol
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



V. N. Nesterova
N.A. Semashko Nizhny Novgorod Regional Clinical Hospital
Russian Federation

603093; 190, Rodionova St.; Nizhny Novgorod
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



Zh. Yu. Chefranova
Belgorod State National Research University
Russian Federation

308015; 85, Pobedy St.; Belgorod
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



T. V. Kharitonova
I.I. Dzhanelidze St. Petersburg Research Institute of Emergency Medicine
Russian Federation

192242; 3, Budapeshtskaya St., lit. A; Saint Petersburg
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



M. V. Sutormin
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation

129110; 61/2, Shchepkina St.; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



O. E. Furman
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation

129110; 61/2, Shchepkina St.; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



A. A. Kulesh
Acad. E.A. Vagner Perm State Medical University, Ministry of Health of Russia; City Clinical Hospital Four
Russian Federation

614990; 26, Petropavlovskaya St.; 614107; 2, KIM St.; Perm
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



N. V. Zhukovskaya
Leningrad Regional Clinical Hospital
Russian Federation

194291; 45/2, Lunacharskogo Prosp.; St. Petersburg
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



K. V. Khoroshavina
Tver Regional Clinical Hospital
Russian Federation

170036; 105, Peterburgskoe Sh.; Tver
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



I. V. Korobeynikov
0Irkutsk Regional Clinical Hospital, winner of the “Mark of the Honor” award
Russian Federation

664049; 100, Yubileyny Microdistrict; Irkutsk
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



O. V. Androphagina
V.D. Seredavin Samara Regional Clinical Hospital
Russian Federation

443095; 159, Tashkentskaya St.; Samara
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



A. A. Bulanov
N.N. Burdenko Penza Regional Clinical Hospital
Russian Federation

440026; 28, Lermontova St.; Penza
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



D. N. Shamalova
Federal Center of Brain and Neurotechnologies, FMBA of Russia
Russian Federation

117997; 1, Ostrovityanova St., Build. 10; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



N. E. Ermachenko
Krasnodar Regional Clinical Emergency Hospital
Russian Federation

350042; 14, 40-Letiya Pobedy St.; Krasnodar
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



V. A. Kutsenko
National Medical Research Center for Therapy and Preventive Medicine, Ministry of Health of Russia
Russian Federation

101000; 10, Petroverigsky Lane; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



O. E. Ivlev
M.V. Lomonosov Moscow State University; National Medical Research Center for Therapy and Preventive Medicine, Ministry of Health of Russia
Russian Federation

119991; 1, Leninskie Gory; 101000; 10, Petroverigsky Lane; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



A. G. Soplenkova
M.V. Lomonosov Moscow State University; National Medical Research Center for Therapy and Preventive Medicine, Ministry of Health of Russia
Russian Federation

119991; 1, Leninskie Gory; 101000; 10, Petroverigsky Lane; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



M. K. Guseva
V.N. Orekhovich Institute of Biomedical Chemistry
Russian Federation

119121; 10, Pogodinskaya St., Build. 8; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



E. A. Karpova
V.N. Orekhovich Institute of Biomedical Chemistry
Russian Federation

119121; 10, Pogodinskaya St., Build. 8; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



A. M. Semenov
SuperGene LLC
Russian Federation

119270; 6, Luzhnetskaya Nab., Build. 1; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



M. P. Semenov
SuperGene LLC
Russian Federation

119270; 6, Luzhnetskaya Nab., Build. 1; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



I. M. Shirshova
SuperGene LLC
Russian Federation

119270; 6, Luzhnetskaya Nab., Build. 1; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



S. V. Ivanov
V.N. Orekhovich Institute of Biomedical Chemistry; SuperGene LLC
Russian Federation

119121; 10, Pogodinskaya St., Build. 8; 119270; 6, Luzhnetskaya Nab., Build. 1; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



Yu. A. Romashova
V.N. Orekhovich Institute of Biomedical Chemistry
Russian Federation

119121; 10, Pogodinskaya St., Build. 8; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



V. V. Beregovykh
V.N. Orekhovich Institute of Biomedical Chemistry
Russian Federation

119121; 10, Pogodinskaya St., Build. 8; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



S. S. Markin
V.N. Orekhovich Institute of Biomedical Chemistry; SuperGene LLC
Russian Federation

119121; 10, Pogodinskaya St., Build. 8; 119270; 6, Luzhnetskaya Nab., Build. 1; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



E. I. Gusev
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; Federal Center of Brain and Neurotechnologies, FMBA of Russia
Russian Federation

117997; 1, Ostrovityanova St.; 1, Ostrovityanova St., Build. 10; Moscow
Competing Interests:

There are no conflicts of interest. The authors are solely responsible for submitting the final version of the manuscript for publication. All the authors have participated in developing the concept of the article and in writing the manuscript. The final version of the manuscript has been approved by all the authors



References

1. Gulli G, Khan S, Markus HS. Vertebrobasilar stenosis predicts high early recurrent stroke risk in posterior circulation stroke and TIA. Stroke. 2009;40(8):2732-7. doi: 10.1161/STROKEAHA.109.553859

2. Anisimov KV, Tolmachev AP, Shamalov NA. Specific features of reperfusion therapy for vertebrobasilar ischemic stroke. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2015;7(3):70-4 (In Russ.). doi: 10.14412/2074-2711-2015-3-70-74

3. Kulesh AA, Demin DA, Vinogradov OI. Differential diagnosis of ischemic stroke in the arteries of the vertebrobasilar system. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2023;15(5):13-9 (In Russ.). doi: 10.14412/2074-2711-2023-5-13-19

4. Mattle HP, Arnold M, Lindsberg PJ, et al. Basilar artery occlusion. Lancet Neurol. 2011;10(11):1002-14. doi: 10.1016/S1474-4422(11)70229-0

5. Gusev EI, Martynov MYu, Nikonov AA, et al. Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4.5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial. Lancet Neurol. 2021;20:721-8. doi: 10.1016/S1474-4422(21)00210

6. Gusev EI, Martynov MYu, Shamalov NA, et al. Non-immunogenic staphylokinase in the treatment of acute ischemic stroke (FRIDA trial results). S.S. Korsakov Journal of Neurology and Psychiatry. 2022;122(7):56-65 (In Russ.). doi: 10.17116/jnevro202212207156

7. Minist.ry of Health of the Russian Federation. Ischemic stroke and transient ischemic attack in adults. Clinical guidelines. Moscow; 2024. Available at: https://cr.minzdrav.gov.ru/view-cr/814_1 (In Russ.).

8. Shamalov NA, Martynov MYu, Yarovaya EB, et al. Thrombolysis with the non- immunogenic staphylokinase for acute ischaemic stroke in FORPI registry: an observational study. Stroke. 2026;57(2):394-403. doi: 10.1161/STROKEAHA.125.051115

9. Shamalov NA, Martynov MYu, Gusev EI, et al. Fortelyzin for acute ischaemic stroke treatment: an open, prospective, noninterventional, observational study FORPI registry. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(12):43-59 (In Russ.). doi: 10.17116/jnevro20251251211

10. Shamalov NA, Martynov MYu, Gusev EI, et al. Fortelyzin in the treatment of acute ischemic stroke in patients ≥ 80 years old: data from the observational study FORPI registry. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;126(3):106-15 (In Russ.). doi: 10.17116/jnevro2026126031106

11. Shamalov NA, Martynov MYu, Gusev EI, et al. Fortelyzin® for acute ischaemic stroke treatment in an extended (4.5 to 24 hours from the onset of symptoms) time window: data from the observational study FORPI registry. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;126(1):82-91 (In Russ.). doi: 10.17116/jnevro202612601182

12. Shamalov NA, Martynov MYu, Khasanova DR, et al. Fortelizin® in bridging therapy of acute ischemic stroke: data from the observational study FORPI registry. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;126(2):59-67 (In Russ.). doi: 10.17116/jnevro202612602159

13. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-29. doi: 10.1056/NEJMoa0804656

14. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007; 369(9558):275-82. doi: 10.1016/S0140-6736(07)60149-4

15. Lindsberg PJ, Pekkola J, Strbian D, et al. Time window for recanalization in basilar artery occlusion: Speculative synthesis. Neurology. 2015;85(20):1806-15. doi: 10.1212/WNL.0000000000002129

16. Lindsberg PJ, Mattle HP. Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke. 2006;37:922-8. doi: 10.1161/01.STR.0000202582.29510.6b

17. Schonewille WJ, Wijman CAC, Michel P, et al. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol. 2009;8:724-30. doi: 10.1016/S1474-4422(09)70173-5

18. Xiong Y, Alemseged F, Cao Z, et al. Tenecteplase versus standard medical treatment for basilar artery occlusion within 24 h (TRACE-5): a multicentre, prospective, randomised, open-label, blinded-endpoint, superiority, phase 3 trial. Lancet. 2026;407(10530):763-72. doi: 10.1016/S0140-6736(25)02633-9

19. Langezaal LCM, van der Hoeven EJRJ, Mont'Alverne FJA, et al. Endovascular Therapy or Stroke Due to Basilar-Artery Occlusion. N Engl J Med. 2021;384(20):1910-20. doi: 10.1056/NEJMoa2030297

20. Räty S, Virtanen P, Ritvonen J, et al. IV thrombolysis in basilar artery occlusion: outcomes and comparison with endovascular thrombectomy. Neurology. 2024;102(8):e209249. doi: 10.1212/WNL.0000000000209249

21. Anisimov KV, Vishnyakova AYu, Ramazanov GR, et al. Thrombolytic therapy in patients with ischemic stroke in the vertebrobasilar system. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2012;4(3):29-34 (In Russ.). doi: 10.14412/2074-2711-2012-399

22. Musin RS, Bekoeva ZR, Kazakov DN, et al. The course of strokes in the vertebrobasilar region under reperfusion therapy. Kremlevskaya medicina. Klinicheskyi vestnik. 2025;(1):60-3 (In Russ.). doi: 10.48612/cgma/mmk6-dt91-zpnm


Review

For citations:

Shamalov NA, Martynov MY, Marskaya NA, Khasanova DR, Yarovaya EB, Voznuk IA, Timchenko LV, Alasheev AM, Khalo NV, Bogatyreva MD, Khan DS, Korsunskaya LL, Nesterova VN, Chefranova ZY, Kharitonova TV, Sutormin MV, Furman OE, Kulesh AA, Zhukovskaya NV, Khoroshavina KV, Korobeynikov IV, Androphagina OV, Bulanov AA, Shamalova DN, Ermachenko NE, Kutsenko VA, Ivlev OE, Soplenkova AG, Guseva MK, Karpova EA, Semenov AM, Semenov MP, Shirshova IM, Ivanov SV, Romashova YA, Beregovykh VV, Markin SS, Gusev EI. Fortelyzin in the treatment of acute ischemic stroke due to basilar-artery occlusion: data from the observational study FORPI registry. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2026;18(2):36-44. (In Russ.) https://doi.org/10.14412/2074-2711-2026-2-36-44

Views: 826

JATS XML


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)

"IMA-PRESS" LLC 
115093, Russian Federation, Moscow,
Partijnyj per, 1, bld. 58, of. 745
E-mail: info@ima-press.net
Phone: +7(495) 926-7814

Processing of personal data
supported by NEICON (Elpub lab)